UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: A randomized controlled trial

PLoS medicine, 2020-06, Vol.17 (6), p.e1003142-e1003142

2020

Volltextzugriff (PDF)

Imlifidase for hematologists: Creating a therapeutic window in the presence of neutralizing alloantibodies

HemaSphere, 2024-01, Vol.8 (1), p.e37-n/a

Schutgens, Roger E. G.

2024

Volltextzugriff (PDF)

COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year

The Lancet. Haematology, 2021-07, Vol.8 (7), p.e524-e533

2021

Volltextzugriff (PDF)

Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial

Trials, 2015-09, Vol.16 (1), p.393, Article 393

2015

Volltextzugriff (PDF)

Aptamers Targeting Von Willebrand Factor: What and Why?

HemaSphere, 2023-02, Vol.7 (2), p.e830-n/a

Schutgens, Roger E. G.

2023

Volltextzugriff (PDF)

Gene Therapy for Hemophilia A: How Long Will It Last?

HemaSphere, 2022-06, Vol.6 (6), p.e720-n/a

Schutgens, Roger E. G.

2022

Volltextzugriff (PDF)

First‐line Therapy for Immune Thrombocytopenia: Time for Change

HemaSphere, 2022-10, Vol.6 (10), p.e783-n/a

Schutgens, Roger E. G.

2022

Volltextzugriff (PDF)

Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded

Haematologica (Roma), 2012-10, Vol.97 (10), p.1507-1513

2012

Volltextzugriff (PDF)

Movement behaviour patterns in adults with haemophilia

Therapeutic advances in hematology, 2020, Vol.11, p.2040620719896959-2040620719896959

2020

Volltextzugriff (PDF)

Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients

American journal of hematology, 2019-05, Vol.94 (5), p.575-584

2019

Volltextzugriff (PDF)

Risk stratification of patients with pulmonary embolism based on pulse rate and D-dimer concentration

Thrombosis and haemostasis, 2009-10, Vol.102 (4), p.683-687

2009

Volltextzugriff (PDF)

Unfavourable cardiovascular disease risk profiles in a cohort of Dutch and British haemophilia patients

Thrombosis and haemostasis, 2013-01, Vol.109 (1), p.16-23

2013

Volltextzugriff (PDF)

Coagulation aggravates blood-induced joint damage in dogs

Arthritis & rheumatology (Hoboken, N.J.), 2012-10, Vol.64 (10), p.3231-3239

2012

Volltextzugriff (PDF)

Tranexamic Acid Is Not a Universal Hemostatic Agent

HemaSphere, 2021-08, Vol.5 (8), p.e625-n/a

2021

Volltextzugriff (PDF)

Increased prevalence of hypertension in haemophilia patients

Thrombosis and haemostasis, 2012-10, Vol.108 (4), p.750-755

2012

Volltextzugriff (PDF)

Glanzmann thrombasthenia complicated by frequent myeloproliferative neoplasm‐related thromboembolism: thrombosis occurring regardless of αIIbβIII integrin deficiency

Clinical case reports, 2021-09, Vol.9 (9), p.e04757-n/a

2021

Volltextzugriff (PDF)

Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions

Cochrane database of systematic reviews, 2015-12 (12), p.CD011385-CD011385

2015

Volltextzugriff (PDF)

Deferasirox limits cartilage damage following haemarthrosis in haemophilic mice

Thrombosis and haemostasis, 2014-11, Vol.112 (5), p.1044-1050

2014

Volltextzugriff (PDF)

A prognostic model for short term adverse events in normotensive patients with pulmonary embolism

American journal of hematology, 2011-08, Vol.86 (8), p.646-649

2011

Volltextzugriff (PDF)

Bleeding phenotype and diagnostic characterization of patients with congenital platelet defects

American journal of hematology, 2020-10, Vol.95 (10), p.1142-1147

2020

Volltextzugriff (PDF)

Non-fatal cardiovascular disease, malignancies, and other co-morbidity in adult haemophilia patients

Thrombosis research, 2012-08, Vol.130 (2), p.157-162

2012

Volltextzugriff (PDF)

Coronary artery calcification in hemophilia A: no evidence for a protective effect of factor VIII deficiency on atherosclerosis

Arteriosclerosis, thrombosis, and vascular biology, 2012-03, Vol.32 (3), p.799-804

2012

Volltextzugriff (PDF)

Towards Personalized Treatment in Haemophilia: The Role of Genetic Factors in Iron and Heme Control to Identify Patients at Risk for Haemophilic Arthropathy

Journal of personalized medicine, 2024-01, Vol.14 (2), p.145

2024

Volltextzugriff (PDF)

Proteoglycan synthesis rate as a novel method to measure blood‐induced cartilage degeneration in non‐haemophilic and haemophilic rats

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-05, Vol.26 (3), p.e88-e96

2020

Volltextzugriff (PDF)

Pathophysiology of hemophilic arthropathy and potential targets for therapy

Pharmacological research, 2017-01, Vol.115, p.192-199

2017

Volltextzugriff (PDF)

1 – 25 von 179

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(169)
Mit Volltextzugriff
(148)

Publikationsform

Sprache

Englisch
(179)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(152)
Science & Technology
(152)
Hematology
(123)
Humans
(99)
Male
(47)
Middle Aged
(46)
Female
(45)
Cardiovascular System & Cardiology
(44)
Peripheral Vascular Disease
(44)
Adult
(41)
Aged
(37)
Hemophilia
(30)
Original
(28)
Biological And Medical Sciences
(27)
Medical Sciences
(27)
Haemophilia
(24)
Hemophilia A - Complications
(20)
Hematologic And Hematopoietic Diseases
(19)
Patients
(19)
Retrospective Studies
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: A randomized controlled trial

Imlifidase for hematologists: Creating a therapeutic window in the presence of neutralizing alloantibodies

COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year

Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial

Aptamers Targeting Von Willebrand Factor: What and Why?

Gene Therapy for Hemophilia A: How Long Will It Last?

First‐line Therapy for Immune Thrombocytopenia: Time for Change

Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded

Movement behaviour patterns in adults with haemophilia

Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients

Risk stratification of patients with pulmonary embolism based on pulse rate and D-dimer concentration

Unfavourable cardiovascular disease risk profiles in a cohort of Dutch and British haemophilia patients

Coagulation aggravates blood-induced joint damage in dogs

Tranexamic Acid Is Not a Universal Hemostatic Agent

Increased prevalence of hypertension in haemophilia patients

Glanzmann thrombasthenia complicated by frequent myeloproliferative neoplasm‐related thromboembolism: thrombosis occurring regardless of αIIbβIII integrin deficiency

Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions

Deferasirox limits cartilage damage following haemarthrosis in haemophilic mice

A prognostic model for short term adverse events in normotensive patients with pulmonary embolism

Bleeding phenotype and diagnostic characterization of patients with congenital platelet defects

Non-fatal cardiovascular disease, malignancies, and other co-morbidity in adult haemophilia patients

Coronary artery calcification in hemophilia A: no evidence for a protective effect of factor VIII deficiency on atherosclerosis

Towards Personalized Treatment in Haemophilia: The Role of Genetic Factors in Iron and Heme Control to Identify Patients at Risk for Haemophilic Arthropathy

Proteoglycan synthesis rate as a novel method to measure blood‐induced cartilage degeneration in non‐haemophilic and haemophilic rats

Pathophysiology of hemophilic arthropathy and potential targets for therapy

Suchergebnisse filtern